Our Mission

Pairing the best human science and tech expertise with the capacity of AI, machine learning and automation to discover high-quality drugs faster is what drives Exscientia.

By applying AI to precision engineer medicine candidates more rapidly and efficiently, we will enable people to live healthier and more productive lives.

To address this challenge, we are re-imagining the way drug discovery is implemented, combining the latest AI techniques with experimental innovation to engineer a new set of processes for drug discovery.

Founded in 2012, we were the first company to automate drug design and are the first to have an AI-designed molecule enter clinical trials.

We focus on implementing AI design as well as precision data generation. Together these maximise the power and fidelity of the integrated AI and machine learning systems.

By focusing on both design and experiment, we are able to significantly accelerate the preclinical drug discovery stage to enable the delivery of new treatments to patients worldwide.